Test new cancer pain medicine with extended-release oxycodone
Treatments studied
Part of Pain clinical trials.
This Phase 2 study tests a new medicine (3D1002) taken together with extended-release oxycodone to improve moderate to severe cancer pain. You may be considered if your cancer pain is stable and you can follow the study’s strict pain-medication rules.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 or older (men or women) and sign consent before any screening
- Have cancer confirmed on a test (biopsy/scan results via histology or cytology)
- Have stable moderate to severe cancer pain and expect to need pain medicine for at least 2 weeks
- Have enough time left (life expectancy of at least 3 months) and can stay on only the study’s allowed pain medicines
- Your pain level during the “washout” period is at least 4 out of 10 on a daily average (NRS)
- Have no key safety problems: no allergy to study drugs/related pain medicines, no recent major stroke, and adequate organ/bone marrow function
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding non-opioid pain relievers (like dipyrone or ibuprofen) to opioid therapy can better manage cancer pain. It may help patients whose pain is not well controlled with opioids alone.
This study tests whether adding electroacupuncture (a treatment using mild electric pulses on needles) and ear acupressure (pressing on specific points on the ear) to the pain medicine hydromorphone helps reduce cancer-related pain that isn't well managed by usual treatments.
This trial tests a topical herbal plaster to see if it can help reduce pain in people with cancer who are already taking opioids. The plaster is placed on the most painful area and may allow you to use less opioid medication.
This trial tests whether a digital multimedia program can help cancer patients better manage pain, stick to their pain medications, and feel more satisfied with their pain control. If you have cancer pain and are taking strong opioids, this study might help you learn new ways to handle your pain.
This trial tests a sustained-release tablet (oxycodone/naloxone) for cancer patients with severe pain and constipation caused by opioids. It aims to see how well the drug works in real-world conditions.
This trial tests an experimental pain medicine (VC004) for people with cancer that has spread to the bones and causes pain. It compares the study drug to a placebo (a dummy pill) to see if it helps with pain and is safe.
Hear when a new Cancer Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.